| FDA Office of Minority Health and Health Equity February 18, 2021 Recommendations About the Use of Dental Amalgam in Certain Higher-Risk Groups The U.S. Food and Drug Administration (FDA) has developed graphics that provide a visualization of recommendations about the use of dental amalgam (a mercury-containing dental restorative or filling material) in certain groups of people who may be at greater risk for potential harmful health effects of mercury exposure. These higher-risk groups are: - Pregnant women and their developing fetuses
- Women who are planning to become pregnant
- Nursing women and their newborns and infants
- Children, especially those younger than six
- People with preexisting neurological disease
- People with impaired kidney function
- People with known heightened sensitivity (allergy) to mercury or other components of dental amalgam.
| Visit the FDA OMHHE website and follow us on Twitter at @FDAHealthEquity "Creating a world where health equity is a reality for all." www.fda.gov/HealthEquity | | | |
No comments:
Post a Comment